Click the title to jump to your preferred section:

Osteoarthritis Knee Outcomes (stromed)

At Cell-Innovations all Doctors and clinics that use our technology continually track the outcomes from patients and have all shown excellent outcomes for their patients. The analysis by our doctors is made possible by the large number of patients (over 800) who have sought stem cell treatment rather than have knee or hip surgery.

Examples of tissue regeneration occurring in the knees of patients are shown in the MRI studies below. Cell-Innovation is constantly improving the use of StroMed to advance consistent tissue regeneration. Please note that the results of every procedure will vary from patient to patient. There is no guarantee you will have tissue regeneration.

Not all patients will respond to stem cell treatment with StroMed results indicating that whilst most knee osteoarthritis patients will be Responders some will be non-responders to the treatment.

Importantly Cell-Innovations now has a simple proprietary test to indicate whether you will likely respond to stem cell treatment for your Osteoarthritis saving the patient undergoing liposuction procedure and fees for treatment if you are classified as a non-responder to stem cell treatment. Talk to your Doctor to have this test.

NB: the data presented below is a compilation of patient outcomes from in-house studies following StroMed treatment.

In 80 knee osteoarthritis patients at 1 year post-StroMed treatment there is an average improvement of 78%

chart

No two patients are alike and patients will vary in their response to StroMed

stromed

MRI coronal images of the knee. The black area underneath the top knee bone indicates cartilage depth. By week 16 a sizeable increase in the regenerated tissue is observed.

MRI

MRI coronal images of the knee. The black area underneath the top knee bone indicates cartilage depth. By week 16 a sizeable increase in the regenerated tissue is observed.

diagram

MRI sagittal images of the knee. The black area underneath the top knee bone indicates cartilage depth. By week 16 a sizeable increase in the regenerated tissue is observed.

diagram_2

The reduction in pain that occurs over time following StroMed treatment may also lead to Doctors recommending patients reduce or stop their anti-inflammatory or pain medication

Note: Any case reports or patient results presented on this web-site are not indicative of all patient results. Like any medical procedure, all regenerative procedures have a success and failure rate.

Osteoarthritis Hip Outcomes

At Cell-Innovations all Doctors and clinics that use our technology continually track the outcomes from patients and have all shown excellent outcomes for their patients.

Patients who have StroMed for osteoarthritis of the hips have demonstrated a very good improvement in their osteoarthritis scores.

Not all patients will respond to stem cell treatment with StroMed results indicating that approximately most will be Responders and a small group non-responders to the treatment.

Importantly Cell-Innovations now has a simple proprietary test to indicate whether you will likely respond to stem cell treatment for your Osteoarthritis saving the patient undergoing liposuction procedure and fees for treatment if you are classified as a non-responder to stem cell treatment. Talk to your Doctor to have this test.

NB: the data presented below is a compilation of patient outcomes from in-house studies following StroMed treatment

 

References

A recent paper presented by Dr Michalek at the 2013 International Federation for Adipose Therapeutics and Science meeting in New York revealed successful results of cell therapy for patients suffering from osteoarthritis

Since 2011, a total of 275 patients have been recruited and followed for up to 24 months to demonstrate the therapeutic potential of freshly isolated SVF cells. At the same time, one to four joints (knees and hips) were injected with SVF cells per patient. A total number of 433 joints were treated.

Within 1-2 weeks from SVF therapy 85% of patients were off the non-steroid analgesics and remained off these analgesics for at least 6 months. After 3 months from SVF therapy, at least 50% clinical improvement was recognized in 95%, at least 75% clinical improvement in 68%, and complete remission in 54% of patients, respectively. Within 1-2 weeks from SVF therapy 85% of patients were off the non-steroid analgesics and remain such for at least 6 months. No serious side effects, infection or cancer was associated with SVF cell therapy.

Semiquantitative clinical scale evaluation and non-steroid analgesics dependence was used as measurement of the clinical effect. Prior to testing, all patients were diagnosed with stage II-IV osteoarthritis using X-ray and ultrasound, in some cases MRI was also performed to monitor the changes before and after stem cell therapy.

This work was supported in part by the International Consortium for Cell Therapy and Immunotherapy and Czech Ministry of Education.

Mickalek J, et al, Autologous adipose tissue-derived stromal vascular fraction cells application in patients with osteoarthritis. Cell Transplant. 2015 Jan 20. doi: 10.3727/096368915X686760

Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis

Almost all patients showed significant improvement in all clinical outcomes at the final follow-up examination. All clinical results significantly improved at 2-year follow-up compared to 12-month follow-up (P < 0.05). Among elderly patients aged >65 years, only five patients demonstrated worsening of Kellgren-Lawrence grade. On second-look arthroscopy, 87.5 % of elderly patients (14/16) improved or maintained cartilage status at least 2 years postoperatively. Moreover, none of the patients underwent total knee arthroplasty during this 2-year period.

Koh et al, Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2015 May;23(5):1308-16. doi: 10.1007/s00167-013-2807-2.

Knee Osteoarthritis

Meniscus Repair

Osteoarthritis of Hips

Tendons

TO OBTAIN FURTHER INFORMATION, DOWNLOAD OUR INFORMATION PACK OR..
BETTER YET, CONTACT US!